RhumbLine Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219M | Sell |
|
|||||
|
2025
Q1 | $240M | Sell |
|
|||||
|
2024
Q4 | $257M | Sell |
|
|||||
|
2024
Q3 | $282M | Sell |
|
|||||
|
2024
Q2 | $279M | Sell |
|
|||||
|
2024
Q1 | $277M | Sell |
|
|||||
|
2023
Q4 | $296M | Sell |
|
|||||
|
2023
Q3 | $346M | Buy |
|
|||||
|
2023
Q2 | $378M | Buy |
|
|||||
|
2023
Q1 | $414M | Buy |
|
|||||
|
2022
Q4 | $500M | Buy |
|
|||||
|
2022
Q3 | $411M | Buy |
|
|||||
|
2022
Q2 | $486M | Buy |
|
|||||
|
2022
Q1 | $453M | Buy |
|
|||||
|
2021
Q4 | $508M | Buy |
|
|||||
|
2021
Q3 | $369M | Buy |
|
|||||
|
2021
Q2 | $328M | Sell |
|
|||||
|
2021
Q1 | $326M | Sell |
|
|||||
|
2020
Q4 | $347M | Sell |
|
|||||
|
2020
Q3 | $344M | Buy |
|
|||||
|
2020
Q2 | $304M | Buy |
|
|||||
|
2020
Q1 | $288M | Buy |
|
|||||
|
2019
Q4 | $344M | Buy |
|
|||||
|
2019
Q3 | $315M | Sell |
|
|||||
|
2019
Q2 | $387M | Sell |
|
|||||
|
2019
Q1 | $392M | Sell |
|
|||||
|
2018
Q4 | $412M | Buy |
|
|||||
|
2018
Q3 | $411M | Sell |
|
|||||
|
2018
Q2 | $344M | Sell |
|
|||||
|
2018
Q1 | $344M | Sell |
|
|||||
|
2017
Q4 | $353M | Buy |
|
|||||
|
2017
Q3 | $339M | Sell |
|
|||||
|
2017
Q2 | $324M | Sell |
|
|||||
|
2017
Q1 | $333M | Buy |
|
|||||
|
2016
Q4 | $308M | Buy |
|
|||||
|
2016
Q3 | $308M | Buy |
|
|||||
|
2016
Q2 | $307M | Buy |
|
|||||
|
2016
Q1 | $245M | Buy |
|
|||||
|
2015
Q4 | $256M | Sell |
|
|||||
|
2015
Q3 | $250M | Buy |
|
|||||
|
2015
Q2 | $263M | Sell |
|
|||||
|
2015
Q1 | $326M | Sell |
|
|||||
|
2014
Q4 | $296M | Sell |
|
|||||
|
2014
Q3 | $286M | Sell |
|
|||||
|
2014
Q2 | $294M | Sell |
|
|||||
|
2014
Q1 | $338M | Buy |
|
|||||
|
2013
Q4 | $318M | Sell |
|
|||||
|
2013
Q3 | $312M | Sell |
|
|||||
|
2013
Q2 | $313M | Buy |
|